Represented a private equity investment firm, and its affiliates, in a $1.5 million follow-on investment through convertible notes in Applied Biological Laboratories, Inc., a New York-based biotechnology company that develops, manufactures, and distributes scientifically-validated natural products used in the treatment of common respiratory illnesses like influenza, coronavirus and asthma.